WILLIAM DEMANT
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
WILLIAM DEMANT - overview
Established
1904
Location
-, -, Denmark
Primary Industry
Medical Devices & Equipment
About
William Demant is a global company specializing in hearing healthcare, providing innovative products and services that improve the auditory experiences of individuals with hearing impairments. Founded in 1904 in Denmark, William Demant focuses on the design and manufacture of hearing aids and related products. The company has expanded its operations globally, with offices located in regions such as North America and Europe. The firm's founder, William Demant, played a pivotal role in developing hearing solutions, and his legacy continues to influence the company's direction.
Demant offers a comprehensive range of innovative products and services in the hearing healthcare industry, including advanced hearing aids, diagnostic equipment, and tailored solutions for hearing care professionals. Their state-of-the-art hearing aids utilize technology that provides personalized sound experiences, catering to various hearing loss conditions. The company serves audiologists, retailers, and healthcare providers, aiming to enhance the hearing capabilities of individuals across multiple markets, including North America, Europe, and parts of Asia. In 2023, William Demant reported a revenue of USD 3.
26 bn and an EBITDA of USD 795. 85 mn. The company's revenue model includes direct-to-consumer sales as well as partnerships with retailers and audiology clinics, which allow for a robust engagement with clients. William Demant’s future growth strategy includes the development of new hearing aid models designed with advanced technology, with anticipated releases in early 2024.
The company aims to expand into emerging markets in Asia and South America by the end of 2025, with funding from recent rounds expected to support product development and market entry initiatives.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.demant.com
Total Amount Raised
Subscriber access only
WILLIAM DEMANT - timeline of key events
WILLIAM DEMANT - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 30, 2012 | Dec 30, 2013 | Dec 30, 2014 | Dec 30, 2015 | Dec 29, 2016 | Dec 29, 2017 | Dec 29, 2018 | Dec 29, 2019 | Dec 29, 2020 | Dec 29, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 6,892,400,000 | 8,041,000,000 | 8,555,000,000 | 9,209,000,000 | 9,346,000,000 | 10,665,000,000 | 12,002,000,000 | 13,189,000,000 | 13,937,000,000 | 14,946,000,000 | 14,469,000,000 | 18,388,000,000 | 19,705,000,000 | - | - | - |
| % Revenue Growth (YoY) | - | 16.7% | 6.4% | 7.6% | 1.5% | 14.1% | 12.5% | 9.9% | 5.7% | 7.2% | (3.2%) | 27.1% | 7.2% | - | - | - |
| EBITDA (USD) | 1,626,700,000 | 1,911,000,000 | 1,891,000,000 | 2,041,000,000 | 2,031,000,000 | 2,177,000,000 | 2,297,000,000 | 2,711,000,000 | 2,942,000,000 | 3,075,000,000 | 2,578,000,000 | 3,941,000,000 | 4,383,000,000 | - | - | - |
| Operating Income (USD) | 1,429,900,000 | 1,709,000,000 | 1,653,000,000 | 1,784,000,000 | 1,761,000,000 | 1,878,000,000 | 1,942,000,000 | 2,338,000,000 | 2,532,000,000 | 2,151,000,000 | 1,530,000,000 | 3,445,000,000 | 3,207,000,000 | - | - | - |
| Operating Margin | 20.7% | 21.3% | 19.3% | 19.4% | 18.8% | 17.6% | 16.2% | 17.7% | 18.2% | 14.4% | 10.6% | 18.7% | 16.3% | - | - | - |
| % EBITDA Margin | 23.6% | 23.8% | 22.1% | 22.2% | 21.7% | 20.4% | 19.1% | 20.6% | 21.1% | 20.6% | 17.8% | 21.4% | 22.2% | - | - | - |
| NET Income (USD) | 988,400,000 | 1,199,000,000 | 1,151,000,000 | 1,311,000,000 | 1,327,000,000 | 1,439,000,000 | 1,464,000,000 | 1,759,000,000 | 1,830,000,000 | 1,467,000,000 | 1,134,000,000 | 2,528,000,000 | 2,084,000,000 | - | - | - |
| % Net Margin | 14.3% | 14.9% | 13.5% | 14.2% | 14.2% | 13.5% | 12.2% | 13.3% | 13.1% | 9.8% | 7.8% | 13.7% | 10.6% | - | - | - |
WILLIAM DEMANT - employee data
WILLIAM DEMANT - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Board Member | BM | ||||||
| Chairman of the Board | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.